177 related articles for article (PubMed ID: 33629779)
1. Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.
Benezeder T; Gehad A; Patra V; Clark R; Wolf P
Exp Dermatol; 2021 Jun; 30(6):841-846. PubMed ID: 33629779
[TBL] [Abstract][Full Text] [Related]
2. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
3. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
[TBL] [Abstract][Full Text] [Related]
4. Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.
Benezeder T; Painsi C; Patra V; Dey S; Holcmann M; Lange-Asschenfeldt B; Sibilia M; Wolf P
Elife; 2020 Jun; 9():. PubMed ID: 32484435
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
[TBL] [Abstract][Full Text] [Related]
6. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical dithranol (Dithrocream
Daunton A; Harries M
Br J Dermatol; 2019 May; 180(5):1246-1247. PubMed ID: 30536990
[No Abstract] [Full Text] [Related]
8. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
Sasmaz S; Arican O
Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
10. Dithranol downregulates expression of Id1 mRNA in human keratinocytes in vitro.
Ronpirin C; Tencomnao T
Genet Mol Res; 2012 Sep; 11(3):3290-7. PubMed ID: 23079823
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
Kagami S; Kishi Y; Hino H
J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line.
George SE; Anderson RJ; Haswell M; Groundwater PW
J Pharm Pharmacol; 2013 Apr; 65(4):552-60. PubMed ID: 23488784
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
[TBL] [Abstract][Full Text] [Related]
15. Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats.
Tang L; Cao L; Pelech S; Lui H; Shapiro J
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):87-90. PubMed ID: 12895001
[TBL] [Abstract][Full Text] [Related]
16. The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata.
He X; Duan X; Liu J; Sha X; Gong Y; Lu W; Li Z; Chen X; Li Y; Shen Z
Phytomedicine; 2021 Jan; 81():153423. PubMed ID: 33310308
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based on clinical studies.
Behrangi E; Roohaninasab M; Sadeghzadeh-Bazargan A; Najar Nobari N; Ghassemi M; Seirafianpour F; Goodarzi A; Dodangeh M
J Cosmet Dermatol; 2022 Jul; 21(7):2727-2741. PubMed ID: 34606676
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Ibrahim SA; Esawy AM; Abdelshafy AS
Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
[TBL] [Abstract][Full Text] [Related]
19. Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin.
Orojan I; Szigeti C; Varszegi S; Dobo E; Gulya K
Brain Res; 2006 Nov; 1121(1):216-20. PubMed ID: 17011532
[TBL] [Abstract][Full Text] [Related]
20. Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT.
Farkas A; Kemény L; Szöny BJ; Bata-Csörgö Z; Pivarcsi A; Kiss M; Széll M; Koreck A; Dobozy A
Inflamm Res; 2001 Jan; 50(1):44-9. PubMed ID: 11235021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
